Haemophilus Influenzae (DBCOND0042063)

Identifiers

Synonyms

H.influenzae / H. influenzae / Haemophilus Influenza / Haemophilus influenzae / Haemophilus influenzae (organism)

Associated Data

Indicated Drugs and Targets

Drug	Description	Targets
Clavulanic acid	A beta lactamase inhibitor used to enhance the effectiveness of beta lactam antibiotics.	Bacterial beta-lactamase enzymestarget Sodium/glucose cotransporter 1transporter Beta-lactamasetarget
Omadacycline	A tetracycline antibiotic used to treat community acquired bacterial pneumonia.	ATP-dependent translocase ABCB1transporter 30S ribosomal protein S3target 30S ribosomal protein S7target 30S ribosomal protein S8target 30S ribosomal protein S19target 30S ribosomal protein S14target 16S ribosomal RNAtarget Albumincarrier

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT02972281	Systematic Search for Primary Immunodeficiency in Adults With Infections	No drug interventions	diagnostic	Not Available	terminated
NCT02692859	A Phase III Clinical Trial of a Haemophilus Influenzae Type b (Hib) Conjugate Vaccine	No drug interventions	prevention	3	completed
NCT01730391	Neisseria Meningitidis Burden of Disease Study	No drug interventions	Not Available	Not Available	completed
NCT00814489	Evaluation of Non-typable Haemophilus Influenzae and Pneumococcal Protein Vaccine Formulations in Young Adults	Hepatitis B Vaccine (Recombinant)	prevention	1	completed
NCT00804284	Database Surveillance Safety Study of PENTACEL® Vaccine	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) Bordetella pertussis fimbriae 2/3 antigen Bordetella pertussis pertactin antigen Bordetella pertussis pertactin antigen (formaldehyde inactivated) Bordetella pertussis toxoid antigen (formaldehyde inactivated) Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen Hepatitis B Vaccine (Recombinant) Poliovirus type 1 antigen (formaldehyde inactivated) Poliovirus type 2 antigen (formaldehyde inactivated) Poliovirus type 3 antigen (formaldehyde inactivated)	Not Available	Not Available	completed
NCT00849069	Study to Assess the Safety of a New GSK Biologicals' GSK2231395A Candidate Vaccine	No drug interventions	prevention	1	terminated